Metastatic Castration Sensitive Prostate Cancer

9 clinical trials · Condition

Record	Firm	Date
A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer (NCT05149131)	Bayer	2022-01-17
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer (NCT04729114)	Astellas Pharma Global Development, Inc.	2021-06-14
Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer (NCT04666129)	Sumitomo Pharma America, Inc.	2021-02-18
Study to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in Japan (NCT04601441)	Kindai University	2020-11-06
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) (NCT04497844)	Janssen Research & Development, LLC	2020-09-23
Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy (NCT02020070)	Memorial Sloan Kettering Cancer Center	2013-12-18

Every clearance here is in the API, with alerts when new ones post.